XML 83 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2021
Intangible Assets [Abstract]  
Summary of Detailed Information About Intangible Assets

(in millions)

 

 

 

 

 

 

 

 

Acquisition costs

 

Goodwill

 

Concessions, licenses, in-process R&D and similar rights

 

Advance payments

 

Total

As of January 1, 2020

 

3.0

 

116.3

 

2.4

 

121.7

Additions

 

 

4.2

 

4.4

 

8.6

Disposals

 

 

  (5.4)

 

  (0.6)

 

  (6.0)

Reclassifications

 

 

0.2

 

  (0.2)

 

Currency differences

 

                           (6.8)

 

  (3.9)

 

 

  (10.7)

Acquisition of subsidiaries and businesses

 

57.5

 

35.8

 

 

93.3

As of December 31, 2020

 

53.7

 

147.2

 

6.0

 

206.9

As of January 1, 2021

 

53.7

 

147.2

 

6.0

 

206.9

Additions

 

 

5.9

 

4.2

 

10.1

Disposals

 

 

  (8.5)

 

  (1.2)

 

  (9.7)

Reclassifications

 

 

1.2

 

  (1.2)

 

Currency differences

 

4.1

 

2.5

 

 

6.6

Acquisition of subsidiaries and businesses

 

 

43.3

 

 

43.3

As of December 31, 2021

 

57.8

 

191.6

 

7.8

 

257.2

 

(in millions)

 

 

 

 

 

 

 

 

Cumulative amortization and impairment charges

 

Goodwill

 

Concessions, licenses, in-process R&D and similar rights

 

Advance payments

 

Total

As of January 1, 2020

 

 

32.3

 

 

32.3

Amortization

 

 

16.6

 

 

16.6

Disposals

 

 

  (5.4)

 

 

  (5.4)

Currency differences

 

 

  (0.1)

 

 

  (0.1)

As of December 31, 2020

 

 

43.4

 

 

43.4

As of January 1, 2021

 

 

43.4

 

 

43.4

Amortization

 

 

16.8

 

 

16.8

Disposals

 

 

  (5.5)

 

 

  (5.5)

Currency differences

 

 

0.1

 

 

0.1

As of December 31, 2021

 

 

54.8

 

 

54.8

 

(in millions)

 

 

 

 

 

 

 

 

Carrying amount

 

Goodwill

 

Concessions, licenses, in-process R&D and similar rights

 

Advance payments

 

Total

As of December 31, 2020

 

53.7

 

103.8

 

6.0

 

163.5

As of December 31, 2021

 

57.8

 

136.8

 

7.8

 

202.4

Summary of Goodwill Recognized

 

 

CGU Immunotherapies

 

External Product Sales of JPT

 

Total

(in millions)

 

As of December 31, 2021

 

As of December 31, 2020

 

As of December 31, 2021

 

As of December 31, 2020

 

As of December 31, 2021

 

As of December 31, 2020

Goodwill

 

57.3

 

53.2

 

0.5

 

0.5

 

57.8

 

53.7